Technical Analysis for BNR - Burning Rock Biotech Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 7.15 | 0.00% | 0.00 |
BNR closed unchanged on Friday, May 31, 2024, on 9 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | 3 days ago |
| Gap Up Closed | 3 days ago |
| 10 DMA Resistance | 3 days ago |
| 2x Volume Pace | 3 days ago |
| 3x Volume Pace | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/28/2024
Burning Rock Biotech develops cancer diagnostic treatment based on deoxyribonucleic acid (DNA). The company provides tumor gene detection, liquid biopsy, hereditary tumor gene detection, tumor benign, and precision clinical trail for lung cancer, breast cancer, colorectal cancer, prostatic cancer, thyroid cancer, and hereditary tumors. Burning Rock Biotech was founded in January 2014, and is based in Guangzhou, China with additional locations in Beijing and Shanghai, China.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Acid Oncology Tumor Breast Cancer Prostate Cancer Colorectal Cancer Lung Cancer Thyroid Biopsy Thyroid Cancer Hereditary Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.1 |
| 52 Week Low | 5.722 |
| Average Volume | 4,364 |
| 200-Day Moving Average | 9.02 |
| 50-Day Moving Average | 7.69 |
| 20-Day Moving Average | 7.78 |
| 10-Day Moving Average | 7.59 |
| Average True Range | 0.50 |
| RSI (14) | 24.24 |
| ADX | 26.09 |
| +DI | 23.70 |
| -DI | 18.95 |
| Chandelier Exit (Long, 3 ATRs) | 7.48 |
| Chandelier Exit (Short, 3 ATRs) | 8.66 |
| Upper Bollinger Bands | 8.41 |
| Lower Bollinger Band | 7.16 |
| Percent B (%b) | -0.01 |
| BandWidth | 16.05 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.0911 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.15 | ||||
| Resistance 3 (R3) | 7.15 | 7.15 | 7.15 | ||
| Resistance 2 (R2) | 7.15 | 7.15 | 7.15 | 7.15 | |
| Resistance 1 (R1) | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 |
| Pivot Point | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 |
| Support 1 (S1) | 7.15 | 7.15 | 7.15 | 7.15 | 7.15 |
| Support 2 (S2) | 7.15 | 7.15 | 7.15 | 7.15 | |
| Support 3 (S3) | 7.15 | 7.15 | 7.15 | ||
| Support 4 (S4) | 7.15 |
